| Literature DB >> 35923438 |
Yuanyuan Lyu1,2, Huafeng Ding1, Jin Ding1, Yonghong Luo1, Xiaoming Guan3, Guantai Ni1.
Abstract
Objective: This study aims to investigate the feasibility and short-term efficacy of single-port laparoscopic-assisted transvaginal natural cavity endoscopic sacrospinous ligament suspensions (SvNOTES).Entities:
Keywords: natural vaginal cavity; pelvic floor dysfunction (PFD); sacrospinal ligament fixation; single-port laparoscopic; surgery
Year: 2022 PMID: 35923438 PMCID: PMC9339651 DOI: 10.3389/fsurg.2022.911553
Source DB: PubMed Journal: Front Surg ISSN: 2296-875X
Figure 1(A) Make a single incision after separating the gap. (B) Placement of homemade single-hole port. (C) Find and isolate the sacrospinous ligament. (D,E) Suture of the sacrospinous ligament.
Characteristics of the study patients (n = 101).
| Characteristics | SSLF ( | SvNOTES ( | |
|---|---|---|---|
| Age (years) | 68 ± 5.2 | 68 ± 4.8 | 0.08 |
| BMI | 25 ± 4.3 | 29 ± 5.1 | 0.04 |
| Delivery times | 3 ± 1 | 2.5 ± 1.5 | 0.52 |
| Preoperative POP-Q scores | |||
| Aa | 0.23 ± 1.0 | 0.31 ± 1.2 | 0.13 |
| Ba | 0.3 ± 1.1 | 0.4 ± 1.3 | 0.21 |
| Ap | −0.6 ± 1.2 | −0.4 ± 1.5 | 0.14 |
| Bp | −0.5 ± 2.0 | −0.4 ± 1.8 | 0.19 |
| C | 2.0 ± 1.7 | 2.6 ± 1.8 | 0.02 |
| TVL | 4.9 ± 0.3 | 6.1 ± 1.9 | 0.25 |
| POP stage before the operation | |||
| II | 15 | 9 | 0.22 |
| III | 10 | 15 | 0.17 |
| IV | 5 | 6 | 0.30 |
Values are given as mean ± SD, number, number (percentage), or median (range), unless indicated otherwise.
Perioperative outcomes by the surgical group.
| Outcome | SSLF ( | SvNOTES ( | |
|---|---|---|---|
| Decrease in oxygen saturation | 0 | 1 | – |
| Conversion to surgery | 0 | 1 | – |
| Blood loss (ml) | 80 ± 10 | 20 ± 14 |
|
| Operative time (minutes) | 30 ± 15 | 60 ± 13 |
|
| Postoperative stay (days) | 3 ± 1 | 4 ± 2 |
|
| Injury | 1 | 0 | – |
| Postoperative fever | 1 | 0 |
|
| Pain | 3 | 7 |
|
| Delayed hemorrhage | 0 | 0 | – |
| Infection | 0 | 0 | – |
| Abscessus | 0 | 0 | – |
Values are given as mean ± SD or number (percentage) unless indicated otherwise.
Bold value indicated p value was meaningful.
Postoperative complications.
| SSLF ( | SvNOTES ( | ||
|---|---|---|---|
| Stress urinary incontinence (SUI) | |||
| Before surgery | 15 | 18 | 0.45 |
| After surgery | – | – | – |
| Improved | 10 | 16 |
|
| Persistent or worsened | 2 | 0 | – |
| Indwelling time of the catheter (days) | 7 ± 2 | 4 ± 1 |
|
| Residual urine (ml) | 110 ± 12 | 90 ± 10 |
|
| Relapse of prolapse | 4 | 1 | |
Values are given as number (percentage) or number unless indicated otherwise.
Bold value indicated p value was meaningful.
Postoperative objective observation indexes.
| POP-Q | SSLF ( | SvNOTES ( | |
|---|---|---|---|
| 6 months | |||
| Aa | −2.6 ± 0.4 | −3.0 ± 0.2 | 0.63 |
| Ba | −2.5 ± 0.3 | −2.8 ± 0.3 | 0.53 |
| Ap | – 2.5 ± 0.2 | −2.9 ± 0.3 | 0.36 |
| Bp | −2.7 ± 0.1 | −2.7 ± 0.2 | 0.28 |
| C | −7.0 ± 0.5 | −8.0 ± 0.5 | < |
| TVL | 7.2 ± 0.7 | 8.1 ± 0.4 | < |
| 12 months | |||
| Aa | −2.3 ± 0.3 | −2.6 ± 0.5 | 0.32 |
| Ba | −2.2 ± 0.3 | −2.5 ± 0.3 | 0.23 |
| Ap | –2.2 ± 0.2 | −2.4 ± 0.4 | 0.55 |
| Bp | −2.5 ± 0.2 | −2.4 ± 0.1 | 0.44 |
| C | −6.9 ± 0.3 | −7.7 ± 0.2 | < |
| TVL | 6.9 ± 0.5 | 7.8 ± 0.1 | < |
| 24 months | |||
| Aa | −2.2 ± 0.8 | −2.3 ± 0.3 | 0.06 |
| Ba | −2.0 ± 0.6 | −2.2 ± 0.3 | 0.13 |
| Ap | −2.0 ± 0.7 | −2.2 ± 0.3 | 0.71 |
| Bp | −2.1 ± 0.5 | −2.2 ± 0.8 | 0.54 |
| C | −6.7 ± 0.4 | −7.5 ± 0.4 | < |
| TVL | 6.7 ± 0.5 | 7.4 ± 0.2 | < |
Values are given as mean ± SD unless indicated otherwise.
Bold value indicated p value was meaningful.
Subjective symptom score at the 2-year follow-up.
| Outcome | SSLF ( | SvNOTES ( | |
|---|---|---|---|
| PFDI-20 score | |||
| Preoperative | 16.21 ± 3.92 | 16.41 ± 4.31 | 0.31 |
| 2-year follow-up | 13.83 ± 0.35 | 11.02 ± 0.31 | 0.02 |
| |
|
| – |
| PFIQ-7 score | |||
| Preoperative | 193.61 ± 46.09 | 194.68 ± 45.21 | 0.59 |
| 2-year follow-up | 90.6 ± 10.5 | 70.7 ± 10.2 | 0.01 |
| |
|
| – |
| POPDI-6 score | |||
| Preoperative | 35.8 ± 9.8 | 37.8 ± 10.5 | 0.56 |
| 2-year follow-up | 9.9 ± 1.8 | 6.8 ± 1.7 | 0.02 |
| |
|
| – |
| UDI-6 score | |||
| Preoperative | 29.4 ± 2.5 | 30.9 ± 2.8 | 0.66 |
| 2-year follow-up | 9.8 ± 1.5 | 6.5 ± 1.5 | 0.01 |
| |
|
| – |
| CRADI | |||
| Preoperative | 25.51 ± 3.1 | 25.89 ± 3.4 | 0.08 |
| 2-year follow-up | 12.2 ± 2.1 | 8.1 ± 2.7 | 0.03 |
| |
|
| – |
| FSFI score | |||
| Preoperative | 5 ± 2 | 4 ± 3 | 0.45 |
| 2-year follow-up | 20 ± 3 | 30 ± 2 | 0.03 |
| |
|
| – |
Values are given as mean ± SD unless indicated otherwise.
Bold value indicated p value was meaningful.